SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016504-08-000034
Filing Date
2008-04-25
Accepted
2008-04-25 15:42:26
Documents
5
Period of Report
2008-04-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 INTEGRATED BIOPHARMA, INC. inb8k_20080425.htm 8-K 13807
2 INTEGRATED BIOPHARMA, INC. exhibit99_1.htm EX-99 17192
3 GRAPHIC nasdaq.gif GRAPHIC 4551
4 INTEGRATED BIOPHARMA, INC. exhibit99_2.htm EX-99 5611
5 GRAPHIC image002.gif GRAPHIC 5044
  Complete submission text file 0001016504-08-000034.txt   51855
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 133035216 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 08777615
SIC: 2834 Pharmaceutical Preparations